Effect Of A Supratherapeutic Dose Of Elpipodect On The QTc Interval for schizophrenia
This study is completed in the United States. It is testing Effect Of A Supratherapeutic Dose Of Elpipodect On The QTc Interval for schizophrenia.
In United States
Compare studies and check their requirements with the research team.
This study is completed in the United States. It is testing Effect Of A Supratherapeutic Dose Of Elpipodect On The QTc Interval for schizophrenia.
In United StatesThis study is completed in the United States, in France, in Bulgaria, .... It is testing Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo for Bipolarity.
In United StatesThis study is completed in the United States. It is testing effects of Basmisanil for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Effects of Once Daily Doses of AQW051 on Cognition, for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Effects of RO5545965 for schizophrenia.
In United StatesThis study is completed in the United States, in Canada, in the United Kingdom, .... It is testing troriluzole for OCD.
In United StatesThis study is completed in the United States, in Bulgaria, in Malaysia, .... It is testing ALKS 9072 (Also Known for schizophrenia.
In United StatesThis study is completed in the United States. It is testing armodafinil Treatment for depression.
In United StatesThis study is completed in the United States. It is testing dasotraline for ADHD.
In United StatesThis study is completed in the United States. It is testing dasotraline for ADHD.
In United StatesThis study is completed in the United States. It is testing ENX-102 for anxiety.
In United StatesThis study is completed in the United States, in Greece, in Lithuania, .... It is testing Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo for Bipolarity.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.